Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.
J Transl Med
; 13: 257, 2015 Aug 07.
Article
in En
| MEDLINE
| ID: mdl-26248464
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
ErbB Receptors
/
Liver Neoplasms
/
Lung Neoplasms
/
Mutation
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Transl Med
Year:
2015
Type:
Article
Affiliation country:
Spain